Close
4

Seqens Seqens

X

CAS 137863-17-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 137863-17-3
Also known as: 137863-17-3, Valsartan methyl ester, Valsartan impurity e, Valsartan related compound e, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-l-valine methyl ester, Methyl (2s)-3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate
Molecular Formula
C25H31N5O3
Molecular Weight
449.5  g/mol
InChI Key
UJTNRXYTECQKFO-QHCPKHFHSA-N
FDA UNII
7BZQ418Z0J

1 2D Structure

CAS 137863-17-3

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate
2.1.2 InChI
InChI=1S/C25H31N5O3/c1-5-6-11-22(31)30(23(17(2)3)25(32)33-4)16-18-12-14-19(15-13-18)20-9-7-8-10-21(20)24-26-28-29-27-24/h7-10,12-15,17,23H,5-6,11,16H2,1-4H3,(H,26,27,28,29)/t23-/m0/s1
2.1.3 InChI Key
UJTNRXYTECQKFO-QHCPKHFHSA-N
2.1.4 Canonical SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)OC
2.1.5 Isomeric SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)OC
2.2 Other Identifiers
2.2.1 UNII
7BZQ418Z0J
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 137863-17-3

2. Valsartan Methyl Ester

3. Valsartan Impurity E

4. Valsartan Related Compound E

5. N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-l-valine Methyl Ester

6. Methyl (2s)-3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate

7. 7bzq418z0j

8. Chembl326349

9. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Methyl Ester

10. L-valine, N-(1-oxopentyl)-n-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, Methyl Ester

11. Unii-7bzq418z0j

12. Valsartan Impurity E [usp-mc]

13. Schembl2251

14. Schembl21619424

15. Dtxsid50468616

16. Bdbm50282365

17. Zinc27079783

18. Akos015899737

19. Akos037647709

20. As-74538

21. Valsartan Related Compound E [usp-rs]

22. D92869

23. A886382

24. Q27268035

25. Methyl N-pentanoyl-n-{[2'-(1h-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-l-valinate

26. Methyl N-pentanoyl-n-{[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-l-valinate

27. N-valeryl-n-[(2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl]-(l)-valine Methyl Ester

28. (2s)-2-[pentanoyl[[2'-(1h-tetrazole-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutyric Acid Methyl Ester

29. (s)-3-methyl-2-{pentanoyl-[2''-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric Acid Methyl Ester

30. (s)-methyl 2-(n-((2\'-(1h-tetrazol-5-yl)-[1,1\'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate

31. (s)-methyl2-(n-((2'-(1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate

32. L-valine,n-(1-oxopentyl)-n-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,methylester

33. Methyl (2s)-3-methyl-2-(n-{[2'-(2h-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoate

34. Methyl (2s)-3-methyl-2-[n-({4-[2-(1h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoate

35. Methyl (2s)-3-methyl-2-[pentanoyl-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate

36. N-[2 Inverted Exclamation Mark -(1h-tetrazol-5-yl)biphenyl-4-yl Methyl]-n-valeryl-(l)-valine Methyl Ester

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 449.5 g/mol
Molecular Formula C25H31N5O3
XLogP34.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count11
Exact Mass449.24268987 g/mol
Monoisotopic Mass449.24268987 g/mol
Topological Polar Surface Area101 Ų
Heavy Atom Count33
Formal Charge0
Complexity623
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY